INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Dec 12, 2018 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- | 20,000 |
Jun 21, 2017 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | $30.63 | 43,950 |
Jun 21, 2017 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | 26,736 |
Jun 14, 2017 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,295 | $21.25 | 44,245 |
Jun 14, 2017 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,295 | -- | -- |
Jul 24, 2009 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 20,423 | $20.14 | 27,236 |
Feb 12, 2014 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 20,865 | $324.44 | 40,907 |
Feb 14, 2012 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 21,352 | $111.01 | 111,405 |
Feb 02, 2024 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 22,713 | $956.65 | 60,056 |
Apr 05, 2011 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Open market or private sale of non-derivative or derivative security | 22,915 | $46.23 | 50,350 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.